Canaccord Genuity analyst Matt Bottomley maintained a Buy rating on Green Thumb Industries (OTC:GTBIF) Inc on Thursday, setting a price target of C$47, which is approximately 10.30% above the present share price of $34.19.
Bottomley expects Green Thumb Industries Inc to post earnings per share (EPS) of $0.04 for the first quarter of 2021.
The current consensus among 8 TipRanks analysts is for a Strong Buy rating of shares in Green Thumb Industries, with an average price target of $43.05.
The analysts price targets range from a high of $62 to a low of $28.08.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $157.1 million and a net profit of $37.21 million. The company's market cap is $7.28 billion.
According to TipRanks.com, Canaccord Genuity analyst Matt Bottomley is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 36.5% and a 57.43% success rate.
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 12 states and operates over 30 cannabis stores under the chains Rise and Essence. Green Thumb is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including Dr. Solomon's, Dogwalkers, and Beboe.